Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11084551rdf:typepubmed:Citationlld:pubmed
pubmed-article:11084551lifeskim:mentionsumls-concept:C0242786lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C0013080lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C1141639lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C0430054lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C0205174lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:11084551lifeskim:mentionsumls-concept:C1705053lld:lifeskim
pubmed-article:11084551pubmed:issue5lld:pubmed
pubmed-article:11084551pubmed:dateCreated2000-12-4lld:pubmed
pubmed-article:11084551pubmed:abstractTextBoth modest screening performance and declining patient and physician acceptance have stimulated interest in alternative markers to the triple screen for the detection of Down syndrome. Our purpose was to compare the concentration of a single urinary analyte, hyperglycosylated human chorionic gonadotropin, with the serum triple screen (alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol concentrations combined with age) for second-trimester Down syndrome detection.lld:pubmed
pubmed-article:11084551pubmed:languageenglld:pubmed
pubmed-article:11084551pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11084551pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11084551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11084551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11084551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11084551pubmed:statusMEDLINElld:pubmed
pubmed-article:11084551pubmed:monthNovlld:pubmed
pubmed-article:11084551pubmed:issn0002-9378lld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:MahoneyM JMJlld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:BaumgartenAAlld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:ColeL ALAlld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:Bahado-SinghR...lld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:ROER DRDlld:pubmed
pubmed-article:11084551pubmed:authorpubmed-author:ShahabiSSlld:pubmed
pubmed-article:11084551pubmed:issnTypePrintlld:pubmed
pubmed-article:11084551pubmed:volume183lld:pubmed
pubmed-article:11084551pubmed:ownerNLMlld:pubmed
pubmed-article:11084551pubmed:authorsCompleteYlld:pubmed
pubmed-article:11084551pubmed:pagination1114-8lld:pubmed
pubmed-article:11084551pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:meshHeadingpubmed-meshheading:11084551...lld:pubmed
pubmed-article:11084551pubmed:year2000lld:pubmed
pubmed-article:11084551pubmed:articleTitleComparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.lld:pubmed
pubmed-article:11084551pubmed:affiliationDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06520-8063, USA.lld:pubmed
pubmed-article:11084551pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11084551pubmed:publicationTypeComparative Studylld:pubmed